Drugs / cisplatin (associated to radiotherapy)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01216020 Comparator | Oct 2010 → May 2015 | head and neck neoplasm, laryngeal neoplasm, oral cavity neoplasm, pharynx neoplasm | Azienda USL 4 Prato | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cisplatin (associated to radiotherapy) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01216020 ↗ |